FDA fully approves Moderna’s Spikevax COVID-19 vaccine.

In a press release on January 31, 2022, the FDA announced the approval of the vaccine which under EUA has been known as Moderna COVID-19 Vaccine, but now approved the vaccine will be marketed as Spikevax for the prevention of COVID-19 in individuals 18 years of age and older, under BLA.  This is the second approved COVID-19 vaccine.  Pfizer’s Cominarty was granted registration August 2021 yet it is still not available in the USA.